Clinical Trial Update: Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing the ICON study, evaluating a combination of an inulin gel with ipilimumab and nivolumab for locally advanced or metastatic rena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma
• Sarcomatoid Renal Cell Carcinoma

Drugs mentioned

• Inulin Gel (inulin)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Sarcomatoid Renal Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING